Resin tablet and use thereof in diagnostic tests

Claim 2

A water-disintegratable tablet for use in clinical diagnostic testing, comprising a predetermined quantity of resilient porous beads composed of polystryene-based anion-exchange resin having quaternary ammonium exchange groups and a particle size within the range of 50 to 600 mesh, said beads being bound together by a water-swellable binder composed essentially of microcrystalline cellulose.

Claim 3

The tablet of claim 1 in which the size range of said beads is 100 to 500 mesh.

Claim 4

The tablet of claim 2 in which the size range of said beads is 200 to 400 mesh.

Claim 5

The tablet of claim 1 in which said polystyrene beads comprise 3 to 9 percent by weight, and said microcrystalline cellulose comprises 90 to 96 percent by weight of said tablet.

Claim 6

The tablet of claim 1 in which said tablet also includes about 1.0 to 5.0 percent by weight of alginic acid.

Claim 7

The tablet of claim 1 in which said beads are formed of a styrene divinyl benzene polymer lattice and said quaternary ammonium exchange groups are in a chloride ionic form.

Claim 8

A water-disintegratable tablet for use in performing clinical diagnostic tests, comprising a predetermined quantity of resilient porous beads composed of a styrene divinyl benzene polymer lattice having quaternary ammonium exchange groups attached thereto and having a particle size within the range of 50 to 600 mesh, said beads being bound together by a water-swellable matrix composed essentially of microcrystalline cellulose, said beads comprising 3 to 9 percent by weight of said tablet and said microcrystalline cellulose comprising 90 to 96 percent by weight of said tablet.

Claim 9

A water-disintegratable tablet for use in performing clinical diagnostic tests, comprising a predetermined quantity of resilient porous beads composed of a styrene divinyl benzene polymer lattice having quaternary ammonium exchange groups attached thereto and having a particle size within the range of 50 to 600 mesh, said beads being bound together by a water-swellable matrix composed essentially of microcrystalline cellulose, said beads comprising 3 to 9 percent by weight of said tablet and said microcrystalline cellulose comprising 90 to 96 percent by weight of said tablet.

Claim 10

The tablet of claim 7 in which said beads have a size within the range of 100 to 500 mesh.

Claim 11

The tablet of claim 8 in which said beads have a size within the range of 200 to 400 mesh.

Claim 12

The tablet of claim 7 in which said matrix also includes alginic acid of 1.0 to 5.0 percent by weight of said tablet.

Claim 13

The tablet of claim 7 in which said quaternary ammonium exchange groups are in a chloride ionic form.

Claim 14

A competitive binding method for measuring serum T4 comprising the steps of mixing a solution of free T4 extracted from a sample of patient's serum with a dilute buffered solution of known radioisotope-labeled T4 bound to saturated TBG, and separating the unbound T4 with an anion-exchange resin, wherein the improvement comprises providing said anion-exchange resin in the form of a tablet consisting essentially of polystyrene-based anion-exchange resin beads of 50 to 600 mesh bound together by microcrystalline cellulose, and performing said mixing and separating steps concurrently without incubating the mixed solutions prior to contact with said tablet.

Claim 15

A competitive binding method for measuring serum T4 comprising the steps of mixing a solution of free T4 extracted from a sample of patient's serum with a dilute buffered solution of known radioisotope-labeled T4 bound to saturated TBG, and separating the unbound T4 with an anion-exchange resin, wherein the improvement comprises providing said anion-exchange resin in the form of a tablet consisting essentially of polystyrene-based anion-exchange resin beads of 50 to 600 mesh bound together by microcrystalline cellulose, and performing said mixing and separating steps concurrently without incubating the mixed solutions prior to contact with said tablet.

Claim 16

The method of claim 12 in which there are the further steps of separating said beads from supernatant by centrifugation and decantation, and thereafter, without washing said beads, measuring the radioactivity of the unbound labeled T4 retained by said beads.

Claim 17

The method of claim 12 in which said beads are of a size within the range of 100 to 500 mesh.

Claim 18

The method of claim 12 in which said beads are of a size within the range of 200 to 400 mesh.

Claim 19

The method of claim 12 in which said polystyrene beads comprise 3 to 9 percent by weight, and said microcrystalline cellulose comprises 90 to 96 percent by weight, of said tablet.

Claim 20

The method of claim 12 in which said polystyrene-based resin beads are formed of a styrene divinyl benzene polymer lattice having quaternary ammonium exchange groups attached thereto.

Claim 21

The method of claim 17 in which said quaternary ammonium exchange groups are in chloride ionic form.

Claim 22

A competitive binding method for measuring serum T4 including the steps of equilibrating a solution of free T4 extracted from a sample of patient's serum with a dilute buffered solution of a known quantity of radioisotope-labeled T4 bound to saturated TBG, and separating the unbound T4 with an anion-exchange resin, wherein the improvement comprises performing said equilibrating and separating steps concurrently by combining said solutions and immediately thereafter introducing into said combined solutions a tablet consisting essentially of polystyrene-based anion-exchange resin beads of a size within the range of 50 to 600 mesh bound together by microcrystalline cellulose.

Claim 23

A competitive binding method for measuring serum T4 including the steps of equilibrating a solution of free T4 extracted from a sample of patient's serum with a dilute buffered solution of a known quantity of radioisotope-labeled T4 bound to saturated TBG, and separating the unbound T4 with an anion-exchange resin, wherein the improvement comprises performing said equilibrating and separating steps concurrently by combining said solutions and immediately thereafter introducing into said combined solutions a tablet consisting essentially of polystyrene-based anion-exchange resin beads of a size within the range of 50 to 600 mesh bound together by microcrystalline cellulose.

Claim 24

The method of claim 19 in which said beads are of a size within the range of 100 to 500 mesh.

Claim 25

The method of claim 19 in which said beads are of a size within the range of 200 to 400 mesh.

Claim 26

The method of claim 19 in which said beads comprise 3 to 9 percent by weight, and said microcrystalline cellulose comprises 90 to 96 percent by weight, of said tablet.

Claim 27

The method of claim 19 in which there are the further steps of segregating said beads and microcrystalline cellulose from supernatant by centrifugation and decantation, and thereafter, without washing said beads, measuring the radioactivity of the unbound labeled T4 retained thereby.